A1ECR

Grapiprant

Created:2024-10-01
Last modified:  2025-11-17
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count64
Chiral Atom Count0
Bond Count67
Aromatic Bond Count22
2D diagram of A1ECR
Chemical Component Summary
NameGrapiprant
Synonyms1-[2-[4-(2-ethyl-4,6-dimethyl-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonyl-urea; methylbenzenesulfonamide
Systematic Name (OpenEye OEToolkits)1-[2-[4-(2-ethyl-4,6-dimethyl-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonyl-urea
FormulaC26 H29 N5 O3 S
Molecular Weight491.605
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESCACTVS3.385CCc1nc2c(C)nc(C)cc2n1c3ccc(CCNC(=O)N[S](=O)(=O)c4ccc(C)cc4)cc3
SMILESOpenEye OEToolkits2.0.7CCc1nc2c(nc(cc2n1c3ccc(cc3)CCNC(=O)NS(=O)(=O)c4ccc(cc4)C)C)C
Canonical SMILESCACTVS3.385 CCc1nc2c(C)nc(C)cc2n1c3ccc(CCNC(=O)N[S](=O)(=O)c4ccc(C)cc4)cc3
Canonical SMILESOpenEye OEToolkits2.0.7 CCc1nc2c(nc(cc2n1c3ccc(cc3)CCNC(=O)NS(=O)(=O)c4ccc(cc4)C)C)C
InChIInChI1.06 InChI=1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32)
InChIKeyInChI1.06 HZVLFTCYCLXTGV-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB12836 
NameGrapiprant
Groups
  • investigational
  • vet_approved
DescriptionGrapiprant, also known as AT-001 and CJ-023, is a drug from the piprant class. These molecules were derived from acylsulfonamide and are characterized to be a novel series of para-N-acylaminomethylbenzoic acid known to be prostaglandin receptor antagonists.[A39838] This type of molecules is currently in development for veterinary patients.[A39816] This class of drugs was defined in 2013 by the World Health Organization.[L4766] Grapiprant has been approved in March 2016 by the FDA's Center for Veterinary Medicine as a non-cyclooxygenase inhibiting NSAID for veterinary use.[A39836]
SynonymsGrapiprant
IndicationThe effects of grapiprant have been investigated in the area of analgesia and anti-inflammation due to the effects that have been reported about this molecule.[A39816] This molecule has been approved and widely accepted to be used in veterinary for pain reduction in arthritis.[A39835] In humans, it has been researched to be used in the control of pain and inflammation associated with osteoarthritis.[A39844, A39843] The effect of grapiprant can be explained through the function of prostaglandin E2 (PGE2) which is a key mediator of swelling redness and pain which are classic signs of inflammation. The effect of PGE2 results from its action through four receptor EP1, EP2, EP3 and EP4 from which the EP4 is the primary mediator of PGE2-driven inflammation.[A39817]
Categories
  • Amides
  • Benzene Derivatives
  • P-glycoprotein substrates
  • Sulfonamides
  • Sulfones
CAS number415903-37-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Prostaglandin E2 receptor EP4 subtypeMSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQK...unknownantagonist
AlbuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownsubstrate
ATP-dependent translocase ABCB1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL3039498
PubChem 11677589
ChEMBL CHEMBL3039498